NRGN and Alzheimer disease: Niklas Mattsson took cerebrospinal fluid from 93 AD patients, 187 MCI patients, and 109 control patients, and investigated the accuracy of t-tau, p-tau, NFL, and neurogranin in their CSF to predict AD (McGrowder et al., 2021).